BCM
JNCE

Beryl Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Beryl Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-610,831
Closed -$1.13M – 28
2023
Q1 		$1.13M Buy
+610,831
New +$1.13M 0.89% 13